India Pharmas Likely To Feel Stronger U.S. FDA Import-Safety Effort
This article was originally published in PharmAsia News
Executive Summary
Indian drug makers are expected to feel the brunt of a new U.S. FDA policy to tighten scrutiny of foreign-made drugs destined for the U.S